Article Information
vol. 56 no. suppl 64
Published By
Print ISSN
Online ISSN
History
- Published online October 28, 2020.
Copyright & Usage
Copyright ©the authors 2020
Author Information
- Emanuela Resta1⇑,
- Giovanna Elisiana Carpagnano2,
- Corrado Pelaia3,
- Maria D'Amato4,
- Nunzio Crimi5,
- Nicola Scichilone6,
- Cecilia Calabrese7,
- Onofrio Resta2,
- Giulia Scioscia8,
- Girolamo Pelaia3 and
- Maria Pia Foschino Barbaro8
- 1Department of Economics, University of Foggia, Foggia, Italy
- 2Respiratory Diseases Section, Department of Basic Medical Sciences Neuroscience and Sense Organs; University of Bari "Aldo Moro", Bari, Italy
- 3Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University "Magna Græcia" of Catanzaro, Catanzaro, Italy
- 4Respiratory Disease Unit, "Dei Colli Monaldi" Hospital, "Federico II" University of Naples, Napoli, Italy
- 5Respiratory Unit, A.O.U. Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy
- 6Biomedical Department of Internal Medicine and Medical Specialties (DIBIMIS), University of Palermo, Palermo, Italy
- 7Department of Translational Medical Sciences, University of Campania "L. Vanvitelli", Napoli, Italy
- 8Institute of Respiratory Diseases, Department of Medical and Surgical Sciences University of Foggia, Foggia, Italy
- Emanuela Resta, Department of Economics, University of Foggia, Foggia, Italy. E-mail: restaemanuela{at}gmail.com
Article usage
Altmetrics
Vol 56 Issue suppl 64
Table of Contents
Cost-effectiveness of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
